Abiopharma

LOBO Announces Pricing of $2 Million Public Offering

NXXT attributes changed: Attr: Fin_status N -> D;

MXCT attributes changed: Attr: Fin_status N -> D;

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

ELBM attributes changed: Attr: Fin_status N -> D;

EJH attributes changed: Attr: Fin_status N -> D;

BIOX attributes changed: Attr: Fin_status N -> D;

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering

The Estée Lauder Companies fait une déclaration concernant une éventuelle transaction avec Puig

Repass Wolfe 🟡 adjusted position in 176 shares (1 derivative) of Fold Holdings, Inc. (FLD) at $1.25 Transaction Date: Mar 19, 2026 | Filing ID: 120342

Dickman Thomas J 🟡 adjusted position in 47 shares (1 derivative) of Fold Holdings, Inc. (FLD) at $1.25 Transaction Date: Mar 19, 2026 | Filing ID: 120341

Dichiarazione di The Estée Lauder Companies sulla potenziale transazione con Puig

Riley Brian Joseph 🟢 acquired 20.0K shares of Global Indemnity Group, LLC (GBLI) Transaction Date: Mar 05, 2026 | Filing ID: 120338

Declaração da The Estée Lauder Companies sobre uma possível transação com a Puig